Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations
NCT ID: NCT00692055
Last Updated: 2008-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
30 participants
INTERVENTIONAL
2008-06-30
2008-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations
NCT00665743
Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg)
NCT00959439
Study Evaluating the Effect of Food on the Bioavailability of PN400 Components
NCT00676442
Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Naprosyn E
NCT00907400
Single/Multiple Dose Bioavailability Trial
NCT00751556
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
PN400
PN400
naproxen 375 mg / esomeprazole 20 mg
2
naproxen 375 mg
Naproxen
naproxen 375 mg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PN400
naproxen 375 mg / esomeprazole 20 mg
Naproxen
naproxen 375 mg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy male or non-pregnant female subjects between 18-55 years as well as other standard inclusion criteria for a study of this nature
Exclusion Criteria:
* Standard exclusion criteria for a study of this nature
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
POZEN
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
POZEN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Austin, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PN400-105
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.